Susquehanna Fundamental Investments’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History
Bought
Maintained
Sold
Other funds holding TMBR
BCM
VF
Susquehanna Fundamental Investments's TMBR Position: Q2 2021 in Review
Susquehanna Fundamental Investments sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2021, closing a stake of 448 shares — an estimated $45K sold.
Susquehanna Fundamental Investments first reported a position in TMBR in Q1 2021 and held it in 1 quarter. The position peaked at $45K in Q1 2021. 15 funds tracked by Wall St. Rank hold TMBR as of Q2 2021.
- Susquehanna Fundamental Investments reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
- Susquehanna Fundamental Investments sold 448 Timber Pharmaceuticals, Inc. shares in Q2 2021, an estimated $45K.
- Susquehanna Fundamental Investments first reported a position in Timber Pharmaceuticals, Inc. in Q1 2021 and held it in 1 quarter.
- Susquehanna Fundamental Investments's Timber Pharmaceuticals, Inc. position peaked at $45K in Q1 2021.
- 15 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2021.
Based on Susquehanna Fundamental Investments's 13F filing for Q2 2021, filed 11 Aug 2021.